Header Logo

Connection

Jeff Slezak to Lymph Node Excision

This is a "connection" page, showing publications Jeff Slezak has written about Lymph Node Excision.
Connection Strength

0.168
  1. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol. 2005 Apr; 173(4):1121-5.
    View in: PubMed
    Score: 0.064
  2. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Mayo Clin Proc. 2001 Jun; 76(6):576-81.
    View in: PubMed
    Score: 0.049
  3. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age. J Urol. 2002 Aug; 168(2):525-9.
    View in: PubMed
    Score: 0.013
  4. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol. 2000 Nov; 164(5):1591-5.
    View in: PubMed
    Score: 0.012
  5. Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison. J Urol. 1999 Apr; 161(4):1223-7; discussion 1227-8.
    View in: PubMed
    Score: 0.010
  6. Cancer volume of lymph node metastasis predicts progression in prostate cancer. Am J Surg Pathol. 1998 Dec; 22(12):1491-500.
    View in: PubMed
    Score: 0.010
  7. Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy. Cancer. 1998 Nov 15; 83(10):2164-71.
    View in: PubMed
    Score: 0.010

© 2024 Kaiser Permanente